Hemispherx BioPharma (HEB)

[JohnnyD3]

HEB has a brilliant CEO and the company is on the verge of commercializing.

Your post makes no sense.

Nature is one of the most prestigious science journals.

Both drugs are now in the 6 top BSL4 labs in North America and Europe. You don;t spend millions in pre clinical work on drugs that are not effective. Here is what the Spiez lab said:

Col. Dr. Sergei Bankoul, M.D., Swiss Armed Forces Logistics, Medical Services Directorate, Head of Medical CBRN Defense of the Armed Forces and Senior Consultant to the Swiss Surgeon General, Major General Andreas Stettbacher, said “We need an effective, convenient-to-use, and widely administrable preventative and therapeutic for pandemic influenza outbreak to accompany the commitment the Swiss Military has made to a rapid, point-of-care diagnostic test for H7N9 to provide a “1:2 punch” to a pandemic threat or outbreak and under our Agreement with the US Department of Defense. Based on research to date, Alferon® is a promising drug candidate.”

Most of HEB trials are paid for by others. the NIH for example in the case of the cancer trials.

HEB has an FDA approved drug with commercial license for the US and S. America for refractory HPV and HepC.

With both drugs in 6 BSL4 labs, future trials, paid for by others, are a certainty.

Not to mention that WHO has apparently approved them for a study - eg they made WHOs short list.

I thought Adam's hit piece was very funny. It sounds to me like like AF might by short in the .20-.30 range and cannot find the shares to cover.